Active options: GILD AAPL BAC FB DIS JPM TWTR NVDA AMD NFLX AMZN FCX MU GM AKAM GE PG

Go back to Active options: GILD AAPL BAC FB DIS JPM TWTR NVDA AMD NFLX AMZN FCX MU GM AKAM GE PG

Gild Sciences (GILD) PT Drops to $75 at BMO on Bad Guidance

February 9, 2017 6:41 AM EST

BMO Capital Markets analyst M. Ian Somaiya maintains Market Perform rating, but drops price target on Gild Sciences (NASDAQ: GILD) to $75 (from $88), as the company delivered guidance well below consensus, forcing the Street to cut estimates.

Somaiya comments, "We are maintaining our Market... More

Gilead Sciences (GILD): 'Acquisition Wanted! - Please Apply Within'

February 8, 2017 11:09 AM EST

Following its 'kitchen sink' HCV guidance and subsequent 9% sell-off, the urgency for Gilead Sciences (NASDAQ: GILD) to make an acquisition continues to intensify. On the call, the company essentially admitted that it cannot grow over the next few years without a... More